Biden weighs in on drug costs in US; The latest health stories from around the world
US President Joe Biden has stepped into a long-running debate about whether the National Institutes of Health (NIH) has legal authority to override an exclusive patent license granted to drug developers if they charge too much for treatments that relied on agency-funded research. In draft policy guidance, the Biden administration says federal agencies would be …
Biden weighs in on drug costs in US; The latest health stories from around the world Read More »